MYC and non-small cell lung carcinoma: LPCAT1 promoted NSCLC proliferation, metastasis and tumorigenesis both in vitro and in vivo and, LPCAT1 promoted NSCLC progression, in part, via the PI3K/AKT/MYC pathway.